(CIDRAP News) The World Health Organization (WHO) replied at greater length today to recent criticism of the way it used science advisors in pandemic planning, defending its response to the H1N1 flu pandemic but allowing that its policies concerning transparency and relations with the pharmaceutical industry need strengthening.
(CIDRAP News) When the H1N1 pandemic influenza began hitting Singapore's military forces last summer, health officials largely arrested its spread by giving oseltamivir to everyone in the affected units, in combination with other preventive steps, according to a report released today.
(CIDRAP News) The head of the World Health Organization (WHO), responding today to recent criticism of WHO policies regarding conflicts of interest and transparency, said the agency needs to tighten its rules for relations with industry but insisted that commercial interests never influenced her decisions regarding the H1N1 influenza pandemic.
Expert warns against H1N1 complacency
(CIDRAP News) Little is known about the safety and efficacy of oseltamivir (Tamiflu) in infants, but German researchers who reviewed cases of babies hospitalized with influenza found the drug yielded benefits similar to those in older children, though mild gastrointestinal symptoms were more common.
Jun 7, 2010
Jun 4, 2010
(CIDRAP News) An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.
(CIDRAP News) Based on an assessment of outside experts, the World Health Organization (WHO) announced today that it is sticking with its current pandemic alert level, based on recurring but low-level activity in some parts of the globe and until it has more information on the Southern Hemisphere's flu season.
(CIDRAP News) Scientists say they have identified factors that helped enable antiviral-resistant seasonal H1N1 influenza viruses, which previously were regarded as evolutionary weaklings, to spread around the world starting in 2007.
